We just couldn’t grow fast enough, Helius CEO reveals amid warning for firms to be ‘realistic’ by Adam Sheldon March 26, 2026March 26, 2026 Helius Therapeutics was well capitalised but just couldn’t grow fast enough to support its cost base, […]
Helius Therapeutics enters voluntary administration, shuts Auckland manufacturing facility by Steve Jones March 11, 2026March 11, 2026
Epsilon posts strongest December quarter following ASX reinstatement by Adam Sheldon January 28, 2026January 28, 2026
Epsilon working with ASX as two-year suspension deadline approaches by Adam Sheldon December 9, 2025December 10, 2025
Directors injected $700K and put up personal property to save Epsilon from collapse, CEO reveals by Steve Jones June 30, 2025June 30, 2025
Health House parent hits financial wall as Melodiol Global Health enters administration by Steve Jones December 13, 2024December 13, 2024
Biortica Agrimed eyes extract manufacturing site as OneLife subsidiaries enter administration by Steve Jones December 5, 2024December 5, 2024
Aether Pacific bids to save business after hitting financial strife by Steve Jones November 26, 2024April 11, 2025
